Literature DB >> 1640227

The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989.

.   

Abstract

The Scottish Motor Neuron Disease Register (SMNDR) is a prospective, collaborative, population based study of motor neuron disease (MND) in Scotland. The register started in January 1989 with the aim of studying the clinical and epidemiological features of MND by prospectively identifying incident patients. It is based on a system of registration by recruitment from multiple sources, followed by the collection of complete clinical data and follow up, mainly through general practitioners. In this report the register's methodology and the demography and incidence data for the first year of study are presented. One hundred and fourteen newly diagnosed patients were identified in 1989 giving a crude incidence for Scotland of 2.24/100,000/year. Standardised incidence ratios showed a non-significant trend towards lower rates in north eastern regions and island areas.

Entities:  

Mesh:

Year:  1992        PMID: 1640227      PMCID: PMC489161          DOI: 10.1136/jnnp.55.7.536

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  33 in total

1.  Epidemiologic investigations of amyotrophic lateral sclerosis. III. A genetic interpretation of incidence and geographic distribution.

Authors:  L T KURLAND
Journal:  Proc Staff Meet Mayo Clin       Date:  1957-08-21

2.  Conjugal amyotrophic lateral sclerosis.

Authors:  E Paolino; E Granieri; M R Tola; G Rosati
Journal:  Ann Neurol       Date:  1983-12       Impact factor: 10.422

3.  Geographic distribution of motor neuron disease and correlation with possible etiologic factors.

Authors:  N E Bharucha; B S Schoenberg; R H Raven; L W Pickle; D P Byar; T J Mason
Journal:  Neurology       Date:  1983-07       Impact factor: 9.910

4.  Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984.

Authors:  S Yoshida; D W Mulder; L T Kurland; C P Chu; H Okazaki
Journal:  Neuroepidemiology       Date:  1986       Impact factor: 3.282

5.  Amyotrophic lateral sclerosis. A case-control study following detection of a cluster in a small Wisconsin community.

Authors:  D G Sienko; J P Davis; J A Taylor; B R Brooks
Journal:  Arch Neurol       Date:  1990-01

6.  Motor neurone disease in the Lothian Region of Scotland 1961-81.

Authors:  S M Holloway; J D Mitchell
Journal:  J Epidemiol Community Health       Date:  1986-12       Impact factor: 3.710

7.  Amyotrophic lateral sclerosis in Middle-Finland: an epidemiological study.

Authors:  K Murros; R Fogelholm
Journal:  Acta Neurol Scand       Date:  1983-01       Impact factor: 3.209

8.  Motor neuron disease in England and Wales, 1959-1979.

Authors:  J Buckley; C Warlow; P Smith; D Hilton-Jones; S Irvine; J R Tew
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-03       Impact factor: 10.154

9.  Amyotrophic lateral sclerosis in Lancashire and South Cumbria, England, 1976-1986. A geographical study.

Authors:  J D Mitchell; H N Gibson; A Gatrell
Journal:  Arch Neurol       Date:  1990-08

10.  Familial adult motor neuron disease: amyotrophic lateral sclerosis.

Authors:  D W Mulder; L T Kurland; K P Offord; C M Beard
Journal:  Neurology       Date:  1986-04       Impact factor: 9.910

View more
  28 in total

1.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

Authors:  A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

Review 2.  Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease.

Authors:  Seth A Bennett; Royena Tanaz; Samantha N Cobos; Mariana P Torrente
Journal:  Transl Res       Date:  2018-10-12       Impact factor: 7.012

Review 3.  Diagnosis and management of motor neurone disease.

Authors:  Christopher J McDermott; Pamela J Shaw
Journal:  BMJ       Date:  2008-03-22

Review 4.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

5.  Diagnostic validity of hospital discharge codes in the ascertainment of amyotrophic lateral sclerosis.

Authors:  Alvaro Alonso
Journal:  Eur J Epidemiol       Date:  2009-12-19       Impact factor: 8.082

6.  Amyotrophic lateral sclerosis: from pathological mechanisms to patient care.

Authors:  G Scarlato
Journal:  J Neurol       Date:  1997-05       Impact factor: 4.849

7.  Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients.

Authors:  C T Jones; R J Swingler; S A Simpson; D J Brock
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

8.  Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease--a record linkage study from the Scottish Motor Neurone Disease Register.

Authors:  Raeburn B Forbes; Shuna Colville; Robert J Swingler
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 9.  The impact of histone post-translational modifications in neurodegenerative diseases.

Authors:  Samantha N Cobos; Seth A Bennett; Mariana P Torrente
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-10-20       Impact factor: 5.187

10.  Genome-wide association reveals three SNPs associated with sporadic amyotrophic lateral sclerosis through a two-locus analysis.

Authors:  Qiuying Sha; Zhaogong Zhang; Jennifer C Schymick; Bryan J Traynor; Shuanglin Zhang
Journal:  BMC Med Genet       Date:  2009-09-09       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.